lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate

C162H195F16LiN28O39 — CID 167532256

IUPAClithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate
SMILESCOC(=O)[C@@H](N)CC1CC1(F)F.COC(=O)[C@@H](N)C[C@@H]1CCCNC1=O.COC(=O)[C@H](CC1CC1(F)F)NC(=O)c1cc2c(OC)cccc2[nH]1.COC(=O)[C@H](C[C@@H]1CCCNC1=O)NC(=O)[C@H](CC1CC1(F)F)NC(=O)c1cc2c(OC)cccc2[nH]1.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@@H](C[C@@H]3CCCNC3=O)C(N)=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@H](C#N)C[C@@H]3CCCNC3=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@H](C#N)C[C@@H]3CCCNC3=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)O)cc12.COc1cccc2[nH]c(C(=O)O)cc12.N[C@@H](CC1CC1(F)F)C(=O)O.O.[Li+].[OH-]
InChIInChI=1S/C25H30F2N4O6.C24H29F2N5O5.2C24H27F2N5O4.C17H18F2N2O4.C16H16F2N2O4.C10H9NO3.C9H16N2O3.C7H11F2NO2.C6H9F2NO2.Li.2H2O/c1-36-20-7-3-6-16-15(20)11-18(29-16)23(34)30-17(10-14-12-25(14,26)27)22(33)31-19(24(35)37-2)9-13-5-4-8-28-21(13)32;1-36-19-6-2-5-15-14(19)10-18(29-15)23(35)31-17(9-13-11-24(13,25)26)22(34)30-16(20(27)32)8-12-4-3-7-28-21(12)33;2*1-35-20-6-2-5-17-16(20)10-19(30-17)23(34)31-18(9-14-11-24(14,25)26)22(33)29-15(12-27)8-13-4-3-7-28-21(13)32;1-24-14-5-3-4-11-10(14)7-12(20-11)15(22)21-13(16(23)25-2)6-9-8-17(9,18)19;1-24-13-4-2-3-10-9(13)6-11(19-10)14(21)20-12(15(22)23)5-8-7-16(8,17)18;1-14-9-4-2-3-7-6(9)5-8(11-7)10(12)13;1-14-9(13)7(10)5-6-3-2-4-11-8(6)12;1-12-6(11)5(10)2-4-3-7(4,8)9;7-6(8)2-3(6)1-4(9)5(10)11;;;/h3,6-7,11,13-14,17,19,29H,4-5,8-10,12H2,1-2H3,(H,28,32)(H,30,34)(H,31,33);2,5-6,10,12-13,16-17,29H,3-4,7-9,11H2,1H3,(H2,27,32)(H,28,33)(H,30,34)(H,31,35);2*2,5-6,10,13-15,18,30H,3-4,7-9,11H2,1H3,(H,28,32)(H,29,33)(H,31,34);3-5,7,9,13,20H,6,8H2,1-2H3,(H,21,22);2-4,6,8,12,19H,5,7H2,1H3,(H,20,21)(H,22,23);2-5,11H,1H3,(H,12,13);6-7H,2-5,10H2,1H3,(H,11,12);4-5H,2-3,10H2,1H3;3-4H,1-2,9H2,(H,10,11);;2*1H2/q;;;;;;;;;;+1;;/p-1/t13-,14?,17-,19-;12-,13?,16-,17-;2*13-,14?,15-,18-;9?,13-;8?,12-;;6-,7-;4?,5-;3?,4-;;;/m000000.000.../s1
InChIKeyJMPGMKGUBQJCRC-OOQLBEHSSA-M
MW3469.41 g/mol
LogP10.74
Rot. Bonds61

About lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate

lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate (PubChem CID 167532256) has the molecular formula C162H195F16LiN28O39 and a molecular weight of 3469.41 g/mol. Its IUPAC name is lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate.

Molecular Properties

Compound Namelithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate
PubChem CID167532256
Molecular FormulaC162H195F16LiN28O39
Molecular Weight3469.41 g/mol
Exact Mass3467.40
IUPAC Namelithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate
SMILESCOC(=O)[C@@H](N)CC1CC1(F)F.COC(=O)[C@@H](N)C[C@@H]1CCCNC1=O.COC(=O)[C@H](CC1CC1(F)F)NC(=O)c1cc2c(OC)cccc2[nH]1.COC(=O)[C@H](C[C@@H]1CCCNC1=O)NC(=O)[C@H](CC1CC1(F)F)NC(=O)c1cc2c(OC)cccc2[nH]1.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@@H](C[C@@H]3CCCNC3=O)C(N)=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@H](C#N)C[C@@H]3CCCNC3=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@H](C#N)C[C@@H]3CCCNC3=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)O)cc12.COc1cccc2[nH]c(C(=O)O)cc12.N[C@@H](CC1CC1(F)F)C(=O)O.O.[Li+].[OH-]
InChIInChI=1S/C25H30F2N4O6.C24H29F2N5O5.2C24H27F2N5O4.C17H18F2N2O4.C16H16F2N2O4.C10H9NO3.C9H16N2O3.C7H11F2NO2.C6H9F2NO2.Li.2H2O/c1-36-20-7-3-6-16-15(20)11-18(29-16)23(34)30-17(10-14-12-25(14,26)27)22(33)31-19(24(35)37-2)9-13-5-4-8-28-21(13)32;1-36-19-6-2-5-15-14(19)10-18(29-15)23(35)31-17(9-13-11-24(13,25)26)22(34)30-16(20(27)32)8-12-4-3-7-28-21(12)33;2*1-35-20-6-2-5-17-16(20)10-19(30-17)23(34)31-18(9-14-11-24(14,25)26)22(33)29-15(12-27)8-13-4-3-7-28-21(13)32;1-24-14-5-3-4-11-10(14)7-12(20-11)15(22)21-13(16(23)25-2)6-9-8-17(9,18)19;1-24-13-4-2-3-10-9(13)6-11(19-10)14(21)20-12(15(22)23)5-8-7-16(8,17)18;1-14-9-4-2-3-7-6(9)5-8(11-7)10(12)13;1-14-9(13)7(10)5-6-3-2-4-11-8(6)12;1-12-6(11)5(10)2-4-3-7(4,8)9;7-6(8)2-3(6)1-4(9)5(10)11;;;/h3,6-7,11,13-14,17,19,29H,4-5,8-10,12H2,1-2H3,(H,28,32)(H,30,34)(H,31,33);2,5-6,10,12-13,16-17,29H,3-4,7-9,11H2,1H3,(H2,27,32)(H,28,33)(H,30,34)(H,31,35);2*2,5-6,10,13-15,18,30H,3-4,7-9,11H2,1H3,(H,28,32)(H,29,33)(H,31,34);3-5,7,9,13,20H,6,8H2,1-2H3,(H,21,22);2-4,6,8,12,19H,5,7H2,1H3,(H,20,21)(H,22,23);2-5,11H,1H3,(H,12,13);6-7H,2-5,10H2,1H3,(H,11,12);4-5H,2-3,10H2,1H3;3-4H,1-2,9H2,(H,10,11);;2*1H2/q;;;;;;;;;;+1;;/p-1/t13-,14?,17-,19-;12-,13?,16-,17-;2*13-,14?,15-,18-;9?,13-;8?,12-;;6-,7-;4?,5-;3?,4-;;;/m000000.000.../s1
InChIKeyJMPGMKGUBQJCRC-OOQLBEHSSA-M
XLogP10.74
TPSA1058.97 Ų
H-Bond Donors29
H-Bond Acceptors40
Rotatable Bonds61
Heavy Atoms246
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003469.41
LogP ≤ 510.74
H-Bond Donors ≤ 529
H-Bond Acceptors ≤ 1040

Analyze lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate?
The IUPAC name of lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate (CID 167532256) is lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate.
What is the SMILES notation for lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate?
The canonical SMILES for lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate is COC(=O)[C@@H](N)CC1CC1(F)F.COC(=O)[C@@H](N)C[C@@H]1CCCNC1=O.COC(=O)[C@H](CC1CC1(F)F)NC(=O)c1cc2c(OC)cccc2[nH]1.COC(=O)[C@H](C[C@@H]1CCCNC1=O)NC(=O)[C@H](CC1CC1(F)F)NC(=O)c1cc2c(OC)cccc2[nH]1.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@@H](C[C@@H]3CCCNC3=O)C(N)=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@H](C#N)C[C@@H]3CCCNC3=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)N[C@H](C#N)C[C@@H]3CCCNC3=O)cc12.COc1cccc2[nH]c(C(=O)N[C@@H](CC3CC3(F)F)C(=O)O)cc12.COc1cccc2[nH]c(C(=O)O)cc12.N[C@@H](CC1CC1(F)F)C(=O)O.O.[Li+].[OH-].
What is the InChIKey of lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate?
The InChIKey is JMPGMKGUBQJCRC-OOQLBEHSSA-M. The full InChI is InChI=1S/C25H30F2N4O6.C24H29F2N5O5.2C24H27F2N5O4.C17H18F2N2O4.C16H16F2N2O4.C10H9NO3.C9H16N2O3.C7H11F2NO2.C6H9F2NO2.Li.2H2O/c1-36-20-7-3-6-16-15(20)11-18(29-16)23(34)30-17(10-14-12-25(14,26)27)22(33)31-19(24(35)37-2)9-13-5-4-8-28-21(13)32;1-36-19-6-2-5-15-14(19)10-18(29-15)23(35)31-17(9-13-11-24(13,25)26)22(34)30-16(20(27)32)8-12-4-3-7-28-21(12)33;2*1-35-20-6-2-5-17-16(20)10-19(30-17)23(34)31-18(9-14-11-24(14,25)26)22(33)29-15(12-27)8-13-4-3-7-28-21(13)32;1-24-14-5-3-4-11-10(14)7-12(20-11)15(22)21-13(16(23)25-2)6-9-8-17(9,18)19;1-24-13-4-2-3-10-9(13)6-11(19-10)14(21)20-12(15(22)23)5-8-7-16(8,17)18;1-14-9-4-2-3-7-6(9)5-8(11-7)10(12)13;1-14-9(13)7(10)5-6-3-2-4-11-8(6)12;1-12-6(11)5(10)2-4-3-7(4,8)9;7-6(8)2-3(6)1-4(9)5(10)11;;;/h3,6-7,11,13-14,17,19,29H,4-5,8-10,12H2,1-2H3,(H,28,32)(H,30,34)(H,31,33);2,5-6,10,12-13,16-17,29H,3-4,7-9,11H2,1H3,(H2,27,32)(H,28,33)(H,30,34)(H,31,35);2*2,5-6,10,13-15,18,30H,3-4,7-9,11H2,1H3,(H,28,32)(H,29,33)(H,31,34);3-5,7,9,13,20H,6,8H2,1-2H3,(H,21,22);2-4,6,8,12,19H,5,7H2,1H3,(H,20,21)(H,22,23);2-5,11H,1H3,(H,12,13);6-7H,2-5,10H2,1H3,(H,11,12);4-5H,2-3,10H2,1H3;3-4H,1-2,9H2,(H,10,11);;2*1H2/q;;;;;;;;;;+1;;/p-1/t13-,14?,17-,19-;12-,13?,16-,17-;2*13-,14?,15-,18-;9?,13-;8?,12-;;6-,7-;4?,5-;3?,4-;;;/m000000.000.../s1.
What are the key properties of lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate?
lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate has a molecular weight of 3469.41 g/mol, XLogP of 10.74, 61 rotatable bonds, 29 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for lithium;(2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoic acid;N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide;bis(N-[(2S)-1-[[(1S)-1-cyano-2-[(3S)-2-oxopiperidin-3-yl]ethyl]amino]-3-(2,2-difluorocyclopropyl)-1-oxopropan-2-yl]-4-methoxy-1H-indole-2-carboxamide);(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoic acid;4-methoxy-1H-indole-2-carboxylic acid;methyl (2S)-2-amino-3-(2,2-difluorocyclopropyl)propanoate;methyl (2S)-2-amino-3-[(3S)-2-oxopiperidin-3-yl]propanoate;methyl (2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoate;methyl (2S)-2-[[(2S)-3-(2,2-difluorocyclopropyl)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]propanoyl]amino]-3-[(3S)-2-oxopiperidin-3-yl]propanoate;hydroxide;hydrate is sourced from PubChem (CID 167532256), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).